Stakeholder acceptability of adolescent participation in clinical trials for biomedical HIV prevention products: considerations from Tanzania and India

References

• AIDS Info UNAIDS. (2018). Trend of new infections. Retrieved from http://aidsinfo.unaids.org/
   Google Scholar
• Blake, D. R., Lemay, C. A., Kearney, M. H., & Mazor, K. M. (2011). Adolescents’ understanding of research concepts: A focus group study. Archives of Pediatrics & Adolescent Medicine, 165(6), 533–539. doi: 10.1001/archpediatrics.2011.87
   PubMed Web of Science ®Google Scholar
• Chakrapani, V., Newman, P. A., Singhal, N., Nelson, R., & Shunmugam, M. (2013). "If it’s Not Working, Why would they Be testing It?” mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India. BMC Public Health, 13(731), doi: 10.1186/1471-2458-13-731
   Google Scholar
• Clark, S., Bruce, J., & Dude, A. (2006). Protecting young women from HIV/AIDS: The case against child and adolescent marriage. International Family Planning Perspectives, 32(2), 79–88. doi:10.1363/ifpp.32.079.06 doi: 10.1363/3207906
   PubMedGoogle Scholar
• Dellar, R. C., Abdool Karim, Q., Mansoor, L. E., Grobler, A., Humphries, H., Werner, L., … Abdool Karim, S. S. (2014). The preventive misconception: Experiences from CAPRISA 004. AIDS and Behavior, 18(9), 1746–1752. doi: 10.1007/s10461-014-0771-6
   PubMed Web of Science ®Google Scholar
• DiClemente, R. J., Ruiz, M. S., & Sales, J. M. (2010). Barriers to adolescents’ participation in HIV biomedical prevention research. Journal of Acquired Immune Deficiency Syndromes, 54(Suppl 1), S12–S17. doi: 10.1097/QAI.0b013e3181e1e2c0
   PubMedGoogle Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS). (2016). Global AIDS update. Geneva: UNAIDS.
   Google Scholar
• HIV Prevention Trials Network. (2018a). A phase 3 double blind safety and efficacy study of long-acting injectable cabotegravir compared to daily oral TDF/FTC for pre-exposure prophylaxis in HIV-uninfected women. Retrieved from https://www.hptn.org/research/studies/hptn084
   Google Scholar
• HIV Prevention Trials Network. (2018b). Evaluation of daily oral PrEP as a primary prevention strategy for young african women: A vanguard study. Retrieved from https://www.hptn.org/research/studies/hptn082
   Google Scholar
• Hosek, S. G., & Zimet, G. D. (2010). Behavioral considerations for engaging youth in HIV clinical research. Journal of Acquired Immune Deficiency Syndromes, 54(Suppl 1), S25–S30. doi: 10.1097/QAI.0b013e3181e15c22
   PubMed Web of Science ®Google Scholar
• Jaspan, H. B., Berwick, J. R., Myer, L., Mathews, C., Flisher, A. J., Wood, R., & Bekker, L.-G. (2006). Adolescent HIV prevalence, sexual risk, and willingness to participate in HIV vaccine trials. The Journal of Adolescent Health, 39(5), 642–648. doi: 10.1016/j.jadohealth.2006.05.016
   PubMed Web of Science ®Google Scholar
• Jaspan, H. B., Soka, N. F., Strode, A. E., Mathews, C., Mark, D., Flisher, A. J., … Bekker, L.-G. (2008). Community perspectives on the ethical issues surrounding adolescent HIV vaccine trials in South Africa. Vaccine, 26(45), 5679–5683. doi: 10.1016/j.vaccine.2008.08.033
   PubMed Web of Science ®Google Scholar
• MacQueen, K. M., & Karim, Q. A. (2007). Practice brief: Adolescents and HIV clinical trials: Ethics, culture, and context. The Journal of the Association of Nurses in AIDS Care, 18(2), 78–82. doi: 10.1016/j.jana.2007.01.002
   PubMed Web of Science ®Google Scholar
• Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., … VOICE Study Team. (2015). Tenofovir-based preexposure prophylaxis for HIV infection among African women. The New England Journal of Medicine, 372(6), 509–518. doi: 10.1056/NEJMoa1402269
   PubMed Web of Science ®Google Scholar
• McGrory, E., Irvin, A., & Heise, L. (2009). Research Rashomon: Lessons from the Cameroon pre-exposure prophylaxis trial site global campaign for microbicides.
   Google Scholar
• Microbicide Trials Network. (2018). MTN-020 – ASPIRE. Retrieved from http://www.mtnstopshiv.org/news/studies/mtn020
   Google Scholar
• Nelson, R. M., Lewis, L. L., Struble, K., & Wood, S. F. (2010). Ethical and regulatory considerations for the inclusion of adolescents in HIV biomedical prevention research. Journal of Acquired Immune Deficiency Syndromes, 54(Suppl 1), S18–S24. doi: 10.1097/QAI.0b013e3181e2012e
   PubMed Web of Science ®Google Scholar
• Newman, P. A., Rubincam, C., Slack, C., Essack, Z., Chakrapani, V., Chuang, D.-M., … Lindegger, G. (2015). Towards a Science of community stakeholder engagement in biomedical HIV prevention trials: An embedded four-country case study. Plos One, 10(8), e0135937. doi: 10.1371/journal.pone.0135937
   PubMed Web of Science ®Google Scholar
• Ott, M. A., Alexander, A. B., Lally, M., Steever, J. B., Zimet, G. D., & Adolescent Medicine Trials Network (ATN) for HIV/AIDS interventions. (2013). Preventive misconception and adolescents’ knowledge about HIV vaccine trials. Journal of Medical Ethics, 39(12), 765–771. doi: 10.1136/medethics-2012-100821
   PubMed Web of Science ®Google Scholar
• Pomfret, S., Karim, Q. A., & Benatar, S. R. (2010). Inclusion of adolescent women in microbicide trials: A publichealth imperative!. Public Health Ethics, 3(1), 39–50. doi: 10.1093/phe/php013
   Web of Science ®Google Scholar
• Rees, H. (2015, February 23). FACTS 001 Phase III trial of Pericoital Tenofovir 1% Gel for HIV prevention in women. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Washington.
   Google Scholar
• Singh, J. A., & Mills, E. J. (2005). The abandoned trials of pre-exposure prophylaxis for HIV: What went wrong? PLoS Medicine, 2(9), e234. doi: 10.1371/journal.pmed.0020234
   PubMed Web of Science ®Google Scholar
• Skoler-Karpoff, S., Ramjee, G., Ahmed, K., Altini, L., Plagianos, M. G., Friedland, B., … Lahteenmaki, P. (2008). Efficacy of Carraguard for prevention of HIV infection in women in South Africa: A randomised, double-blind, placebo-controlled trial. The Lancet, 372(9654), 1977–1987. doi: 10.1016/S0140-6736(08)61842-5
   PubMed Web of Science ®Google Scholar
• Strode, A., & Essack, Z. (2017). Facilitating access to adolescent sexual and reproductive health services through legislative reform: Lessons from the South African experience. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, 107(9), 741–744. doi: 10.7196/SAMJ.2017.v107i9.12525
   PubMed Web of Science ®Google Scholar
• Tolley, E. E., Kaaya, S., Kaale, A., Minja, A., Bangapi, D., Kalungura, H., … Baumgartner, J. N. (2014). Comparing patterns of sexual risk among adolescent and young women in a mixed-method study in Tanzania: Implications for adolescent participation in HIV prevention trials. Journal of the International AIDS Society, 17(3 Suppl 2), 19149. doi: 10.7448/IAS.17.3.19149
   PubMedGoogle Scholar
• Tolley, E. E., Ulin, P. R., Mack, N., Robinson, E. T., & Succop, S. M. (2016). Qualitative methods in public health: A field guide for applied research (2nd ed.). San Francisco, CA: Wiley.
   Google Scholar
• Vallely, A., Lees, S., Shagi, C., Kasindi, S., Soteli, S., Kavit, N., … Microbicides Development Programme (MDP). (2010). How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania. BMC Medical Ethics, 11, 10. doi: 10.1186/1472-6939-11-10
   PubMed Web of Science ®Google Scholar